Landa Propato
Physician Assistant · Montgomeryville, PANPI 1033293931
Payments from drug & device makers
Across 109 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$369
- Novo Nordisk$286
- AstraZeneca$225
- Pfizer$133
- Bayer$77
- Boehringer Ingelheim$72
- plus $569 from 18 others
What the payments were for
- Food & beverage$1,732100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 33 | $369 |
| Novo Nordisk | 15 | $286 |
| AstraZeneca | 14 | $225 |
| Pfizer | 7 | $133 |
| Bayer | 4 | $77 |
| Boehringer Ingelheim | 4 | $72 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $70 |
| Sanofi-aventis U.S. LLC | 4 | $65 |
| Amgen | 3 | $46 |
| Abbott | 2 | $46 |
| GSK | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 3 | $44 |
| Lilly USA, LLC | 3 | $42 |
| Johnson & Johnson | 2 | $37 |
| Fidia Pharma USA Inc. | 1 | $23 |
| Vertos Medical, Inc. | 1 | $21 |
| Exact Sciences | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Merck | 1 | $16 |
| Bausch Health US, LLC | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Kaleo, Inc. | 1 | $12 |
How this compares
$1,732 in reported general payments places this provider in the 80th percentile of 6,643 physician assistant providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 26 | $36,843 |
| JardianceEmpagliflozin | 34 | $34,841 |
| OzempicSemaglutide | 34 | $33,995 |
| MounjaroTirzepatide | 13 | $13,151 |
| Novolog FlexpenInsulin Aspart | 12 | $3,188 |
| Atorvastatin Calcium | 250 | $3,012 |
| Levothyroxine Sodium | 225 | $2,805 |
| Rosuvastatin Calcium | 132 | $2,557 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 27 | $2,417 |
| Lisinopril | 284 | $2,388 |
| SynthroidLevothyroxine Sodium | 25 | $1,741 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $1,722 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 75 | $1,675 |
| Losartan Potassium | 134 | $1,477 |
| Valsartan | 41 | $1,243 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $133 | $36,84326 claims |
| Boehringer IngelheimJardiance | $72 | $34,84134 claims |
| Novo NordiskOzempic | $286 | $33,99534 claims |
| Lilly USA, LLCMounjaro | $42 | $13,15113 claims |
| AbbVieSynthroid | $369 | $1,74125 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,643 physician assistant providers in Pennsylvania.
Other physician assistant in Montgomeryville
- Erin CrownState College$1.5M
- Tricia BootsCranberry Twp$313K
- Melissa FerrariPhiladelphia$223K
- Jason OberdickWexford$206K
- Justine RobertsMurrysville$173K
- Allison BoydErie$163K
- Joshua TrbovichWashington$144K
- Daniel TelegaErie$124K
- Alvin KingcadePhiladelphia$101K
- Jeffrey CameronWashington$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.